No products in the cart.
ANALYTICAL METHODS
ANALYTICAL EVALUATION FRAMEWORK
Icarus Peptides utilizes standardized analytical methodologies designed to support molecular identity confirmation, purity evaluation, and batch-level verification continuity across released production lots.
Analytical testing functions as part of the release authorization framework and is performed prior to distribution eligibility.
The objective of analytical evaluation is documentation-based verification. Not promotional validation.
CORE ANALYTICAL SYSTEMS
- RP-HPLC Analysis Chromatographic purity profiling and impurity separation evaluation.
- Mass Spectrometry Molecular identity confirmation and structural consistency review.
- Impurity Monitoring Controlled evaluation of synthesis-related deviations and fragments.
- Analytical Continuity Lot-linked archival systems supporting traceability and verification continuity.
- RP-HPLC
PURITY ANALYSIS
- MS
IDENTITY CONFIRMATION
- C18 / C4
STATIONARY PHASES
- LOT-SPECIFIC
DATA ARCHITECTURE
RP-HPLC
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC)
RP-HPLC is utilized to evaluate chromatographic purity profiles within synthesized peptide lots.
The methodology separates molecular components based on retention behavior and interaction characteristics, allowing analytical review of:
- chromatographic peak distribution,
- impurity presence,
- peak separation consistency,
- and overall purity characteristics.
Depending on analytical requirements and compound characteristics, calibrated C18 or C4 stationary phases may be utilized during evaluation procedures.
Purity reporting remains specific to the originating production lot.
MASS SPECTROMETRY
Mass Spectrometry (MS)
Mass Spectrometry is utilized to confirm molecular identity and mass consistency across synthesis lots.
MS evaluation supports:
- molecular identity confirmation,
- structural consistency review,
- and batch-level verification procedures.
Depending on analytical requirements, Electrospray Ionization (ESI) or Matrix-Assisted Laser Desorption/Ionization (MALDI) methodologies may be utilized during analytical review workflows.
IMPURITY REVIEW
Impurity Review Procedures
Analytical evaluation may include monitoring for:
- process-related impurities,
- incomplete coupling sequences,
- truncated peptide fragments,
- and synthesis-related deviations.
Impurity analysis functions as part of the controlled release assessment framework.
ANALYTICAL CONTINUITY
Analytical Continuity
All analytical datasets remain linked directly to their originating production lots through the batch identification framework.
Analytical records are archived to preserve:
- traceability,
- verification continuity,
- documentation accessibility,
- and lot-level analytical integrity.